104 related articles for article (PubMed ID: 12056716)
1. The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Germann N; Gross-Goupil M; Wasserman E; Emile JF; Misset JL; Reynes M; Goldwasser F
Ann Oncol; 2002 Apr; 13(4):632-6. PubMed ID: 12056716
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Soulié P; Garrino C; Bensmaïne MA; Bekradda M; Brain E; Di Palma M; Goupil A; Misset JL; Cvitkovic E
J Cancer Res Clin Oncol; 1999 Dec; 125(12):707-11. PubMed ID: 10592105
[TBL] [Abstract][Full Text] [Related]
3. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
4. Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case Report.
Choi JE; Choe AR; Yoon SE; Nam EM; Park H; Lee KE
Chemotherapy; 2017; 62(1):54-57. PubMed ID: 27351795
[TBL] [Abstract][Full Text] [Related]
5. An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie Pédiatrique.
Baranzelli MC; Patte C; Bouffet E; Portas M; Mechinaud-Lacroix F; Sariban E; Roche H; Kalifa C
J Neurooncol; 1998 May; 37(3):229-39. PubMed ID: 9524081
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
Ryoo BY; Kang YK; Im YH; Kim YJ; Kim BS; Kim TY; Jung SH; Park JH; Baek HJ; Kim YC; Shim YM; Kim CM; Zo JI
Am J Clin Oncol; 1999 Jun; 22(3):253-7. PubMed ID: 10362331
[TBL] [Abstract][Full Text] [Related]
7. Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report.
Waseda Y; Komai Y; Yano A; Fujii Y; Noguchi N; Kihara K
Jpn J Clin Oncol; 2012 Dec; 42(12):1197-201. PubMed ID: 23071288
[TBL] [Abstract][Full Text] [Related]
8. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
Horwich A; Brada M; Nicholls J; Jay G; Hendry WF; Dearnaley D; Peckham MJ
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.
Keskin S; Ekenel M; Başaran M; Bavbek S
Am J Clin Oncol; 2012 Aug; 35(4):369-72. PubMed ID: 22814307
[TBL] [Abstract][Full Text] [Related]
10. Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?
Crawford SM; Ledermann JA; Turkie W; Rustin GJ; Begent RH; Newlands ES; Bagshawe KD
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1483-7. PubMed ID: 2439342
[TBL] [Abstract][Full Text] [Related]
11. Complete pathologic response with combination oxaliplatin and 5-fluorouracil chemotherapy in an older patient with advanced gastric cancer.
Amini A; Sanati H
Anticancer Drugs; 2011 Nov; 22(10):1024-6. PubMed ID: 21822120
[TBL] [Abstract][Full Text] [Related]
12. [Palliative surgery combined with oxaliplatin-based chemotherapy in treatment of patients with advanced gastric cancer].
Chen YB; Guan YX; Zhan YQ; Li W; Sun XW; Li YF; Xu DZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1520-2. PubMed ID: 15566671
[TBL] [Abstract][Full Text] [Related]
13. [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
Takahashi T; Kochi M; Kanamori N; Kaiga T; Funada T; Fujii M; Takayama T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1885-8. PubMed ID: 19920393
[TBL] [Abstract][Full Text] [Related]
14. Rectal adenocarcinoma with germ-cell differentiation: report of a case.
Coleman TA; Redger CD; Hamill RL; Dainer P
Dis Colon Rectum; 2003 Dec; 46(12):1702-5. PubMed ID: 14668599
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
Bozkaya Y; Doğan M; Yazıcı O; Erdem GU; Demirci NS; Zengin N
Bosn J Basic Med Sci; 2017 May; 17(2):138-143. PubMed ID: 28273032
[TBL] [Abstract][Full Text] [Related]
16. [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
Lou F; Zhu YH; Pan HM
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):75-8. PubMed ID: 19538878
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between the effects of irinotecan or oxaliplatin combined with capecitabine in the treatment of advanced gastric cancer].
Zhao WY; Chen DY; Qi Q
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):295-8. PubMed ID: 21575503
[TBL] [Abstract][Full Text] [Related]
18. Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
Kripp M; Ströbel P; Dinter D; Lukan N; Hochhaus A; Hofheinz RD
Anticancer Drugs; 2009 Jan; 20(1):75-8. PubMed ID: 19343004
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer.
Kim HS; Ryu MH; Zang DY; Ryoo BY; Yang DH; Cho JW; Lim MS; Kim MJ; Han B; Choi DR; Kim JH; Jung JY; Song H; Park CK; Kang YK
Gastric Cancer; 2016 Apr; 19(2):579-585. PubMed ID: 25997815
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
